Hemodynamic Monitoring Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented by Product (Disposable v/s Monitors), By Type (Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, Non-invasive Hemodynamic Monitoring Systems), By End User (Hospitals, Clinics, and Ambulatory Care Centres), By Region, and Competition Pages

The Global Hemodynamic Monitoring System Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing developments in hemodynamic monitoring systems, and growth enhancement in the research of hemodynamic monitoring systems across the globe. Additionally, the increasing prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, and vascular diseases, and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about hemodynamic monitoring systems and procedural benefits provided by monitoring systems for the treatment of cardiovascular diseases is further boosting the market growth during the forecast period. Cardiovascular disease (CVD), listed as the underlying cause of death, accounted for 874,613 deaths in the United States in 2019. Hemodynamic monitoring systems are often expensive, which can make them difficult to afford for some healthcare providers, particularly in low- and middle-income countries. This can limit the adoption of these devices, particularly in resource-limited settings. The lack of adequate reimbursement policies can limit the adoption of hemodynamic monitoring systems, particularly in healthcare systems where costs are borne by patients or healthcare providers. The development and approval of hemodynamic monitoring systems can be a lengthy and costly process due to regulatory hurdles, such as obtaining regulatory approval from the US Food and Drug Administration (FDA) or the European Medicines Agency (EMA). Alternative technologies, such as non-invasive monitoring devices and wearable sensors, may compete with hemodynamic monitoring systems. These devices may be more convenient and less invasive, making them more attractive to some healthcare providers and patients. The PULSION Medical Systems PiCCOsmarT system is a hemodynamic monitoring platform that provides real-time data on cardiac output, stroke volume, and other key parameters using a minimally invasive catheter system. The system includes advanced algorithms to provide accurate and reliable data and can be used in a variety of clinical settings, including intensive care units and operating rooms.

Technological advancements

According to recent research, it has been observed that the increasing demand for non-invasive technologies is rapidly growing over conventionally accepted invasive technology in present years. These monitoring systems help to diagnose pain and reduce the risk of blood-borne infections in patients. Similarly, these systems are easy to use and can be operated by a nurse without the supervision of a doctor or any specialist. Due to its advantages, these systems can be simultaneously monitored in different patients which lower the cost of staff and treatment expenditure. Additionally, the growing usage of hemodynamic monitoring for CVP, hemodynamic monitoring non-invasive systems, hemodynamic monitoring invasive systems, hemodynamic monitoring during CPB, hemodynamic monitoring transducers, hemodynamic monitoring transducers, hemodynamic monitoring cardiogenic shocks, hemodynamic monitoring echocardiography, hemodynamic monitoring flotrac , hemodynamic monitoring in heart failure, haemorrhage, arterial line, etc are expected to create a lucrative growth during the forecast period. Similarly, the expansion of the hemodynamic monitoring systems market and devices market are boosting the market growth rate during the forecast period. In March 2021, Philips introduced its interventional hemodynamic system featuring a patient monitor- IntelliVue X3 to provide advanced hemodynamic (blood flow) measurements and improve patient focus during image-guided procedures. The development of new and advanced hemodynamic monitoring systems, such as minimally invasive devices and wireless monitoring systems, is driving the growth of the market. These devices offer greater accuracy, convenience, and reduced risk of infection, making them more attractive to healthcare providers. Several government initiatives aimed at improving healthcare infrastructure and promoting the adoption of advanced medical technologies are expected to drive the growth of the hemodynamic monitoring system market. For example, the Affordable Care Act in the US includes provisions that encourage the adoption of innovative medical devices and technologies. Advances in data analytics and visualization have led to the development of hemodynamic monitoring systems that provide real-time data visualization and analysis, allowing healthcare providers to quickly identify trends and make informed clinical decisions. There has been an increased focus on patient safety in hemodynamic monitoring, with efforts to reduce the risk of infection associated with invasive monitoring procedures, such as the use of antimicrobial-coated catheters. The Cheetah Medical Starling SV system is a non-invasive hemodynamic monitoring platform that uses bioimpedance technology to provide real-time data on stroke volume, cardiac output, and other key hemodynamic parameters. The system includes a lightweight sensor that is placed on the patient's chest and does not require any invasive procedures.

Growing Prevalence of Cardiovascular Diseases

Advanced hemodynamic monitoring methods can enhance the monitoring systems of cardiac patients during post-operative care and anaesthesia - repetitive measurements for the detection of hemodynamic abnormalities and their causes. Cardiovascular diseases are one of the major chronic diseases across the world. Coronary heart syndrome, cerebrovascular diseases, rheumatic heart diseases, and other illnesses are among them blood vessel disorders known as CVDs. According to WHO, 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year. Furthermore, the increasing burden of CVDs triggers the increased adoption of hemodynamic monitoring systems during the forecast period. 96 million people aged 18 years or older have prediabetes in the United States and Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents. The rising incidence of cardiovascular diseases, such as heart failure, hypertension, and coronary artery disease, is one of the primary drivers of the hemodynamic monitoring system market. These conditions often require constant monitoring of hemodynamic parameters to ensure adequate blood flow and oxygen delivery to vital organs. The aging population is another significant driver of the hemodynamic monitoring system market. Older adults are more susceptible to cardiovascular diseases and are more likely to require hemodynamic monitoring during surgical procedures and in the ICU. The growing trend towards minimally invasive procedures is driving the demand for hemodynamic monitoring systems that can provide accurate data without invasive procedures. These procedures are often performed in ambulatory surgical centers, which are expected to be a significant growth area for the hemodynamic monitoring system market. Exposure to air pollution, particularly fine particulate matter (PM2.5), has been linked to an increased risk of CVD. Air pollution can contribute to the development of hypertension, atherosclerosis, and myocardial infarction. Family history of CVD is a significant risk factor for the development of the disease. Some genetic factors increase the risk of CVD, such as familial hypercholesterolemia, which is an inherited condition that causes high levels of cholesterol in the blood. Urbanization is associated with increased levels of physical inactivity, stress, and unhealthy dietary habits, which can contribute to the development of CVD. The Edwards Lifesciences HemoSphere system is a comprehensive hemodynamic monitoring platform that provides real-time data on key hemodynamic parameters, including cardiac output, stroke volume, and systemic vascular resistance. The system uses advanced algorithms to provide accurate and reliable data, and includes a variety of catheter options to meet the needs of different patient populations.

Recent Development

• One such minimally/non-invasive Hemodynamic Monitor is made by renowned UK-based manufacturer LiDCO, the LiDCOrapid, with minimally invasive monitoring via the standard radial arterial line and one cost-effective disposable.
• In February 2022, Caretaker Medical received the US Food and Drug Administration (FDA) clearance to add four new parameters on its next-generation VitalStream wireless ‘beat-by-beat’ blood pressure and hemodynamic monitoring platform, to include stroke volume, cardiac output, left ventricular ejection time, and heart rate variability.
• In July 2022, Retia Medical received Series B funding of $15 million led by Fresenius Medical Care Ventures to expand its commercial team and accelerate the development and commercialization of its Argos Hemodynamic Monitor.
• In 2020, Philips, a leading provider of healthcare technology, acquired Xhale Assurance, a company specializing in non-invasive monitoring technologies. The acquisition expanded Philips' portfolio of monitoring systems and provided access to new technologies for non-invasive monitoring of key hemodynamic parameters.\
• In 2020, ICU Medical, a leading provider of infusion therapy and critical care products, acquired the hemodynamic monitoring product line of Cheetah Medical, a company specializing in non-invasive monitoring technologies. The acquisition expanded ICU Medical's portfolio of monitoring systems and provided access to new technologies for non-invasive monitoring of key hemodynamic parameters.
• In 2019, Baxter International, a leading provider of renal and hospital products, acquired Cheetah Medical, a company specializing in non-invasive monitoring technologies. The acquisition expanded Baxter International's portfolio of monitoring systems and provided access to new technologies for non-invasive monitoring of key hemodynamic parameters.

Download Free Sample Report

Market Segmentation

The global hemodynamic monitoring system market can be segmented by product, type, end-user, and region. Based on the product, the market can be divided into Disposable and Monitors. Based on type, the market can be grouped into Invasive Hemodynamic Monitoring Systems, Minimally Invasive Hemodynamic Monitoring Systems, and Non-invasive Hemodynamic Monitoring Systems. Based on end users, the market can be segmented into Hospitals, Clinics, and Ambulatory Care Centers. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global hemodynamic monitoring market on account of the growing demand for minimally invasive surgeries with low costs for the treatment of cardiovascular diseases.

Market Players

Edwards Lifesciences Corporation, Pulsion Medical Systems Se., Lidco Group Limited., Deltex Medical Group PLC., ICU Medical Inc., Cnsystems Medizintechnik GmbH., Caretaker Medical Inc., Osypka Medical GmbH., Cheetah Medical., NI Medical., Uscom. are some of the leading players operating in the Global Hemodynamic Monitoring System Market.

Report Scope:

In this report, the global hemodynamic monitoring systems market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Hemodynamic Monitoring Systems Market, By Product:

o    Disposable

o    Monitors

• Hemodynamic Monitoring Systems Market, By Type:

o    Invasive Hemodynamic Monitoring Systems

o    Minimally Invasive Hemodynamic Monitoring Systems

o    Non-invasive Hemodynamic Monitoring Systems

• Hemodynamic Monitoring Systems Market, By End Users:

o    Hospitals

o    Clinics

o    Ambulatory Care Centers

• Hemodynamic Monitoring Systems Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hemodynamic Monitoring Systems Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Hemodynamic Monitoring Systems Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]